A Not For Profit Organization Dedicated To Vascular Education And Research

“The interaction between clinicians, interventionists, trialists, and policy makers keeps VIVA on the cutting edge.”

“Looking at procedures and technology with unique insight helps to improve the outcome of patients.”

“Intellect, interaction, and innovation are available at your fingertips at the speed you want to learn.”

THE PREMIER MULTIDISCIPLINARY VASCULAR EDUCATION EVENTTHE PREMIER MULTIDISCIPLINARY VASCULAR EDUCATION EVENT

10A n n i v e r s A r yTH

2

THE VIVA SYMPOSIUM

CELEbRATINg 10 YEARS Of ExCELLENCE

This year, VIVA®, Vascular InterVentional Advances, celebrates its 10th year of defining excellence in vascular

medicine and intervention. VIVA 12 offers a jam-packed week of exciting educational sessions for all those involved

in the care of patients with vascular disease. For this milestone year, VIVA attendees will experience an incredible

symposium, including presentations from a world renowned, multispecialty, international faculty, expanded

concurrent and pre-course sessions, state-of-the-art technology with 3D learning tools, and a special evening

anniversary event.

Since 2003, VIVA has focused intently on keeping the annual conference innovative and fresh, while remaining

devoted to the goal of advancing the field of vascular medicine through interdisciplinary education. VIVA has

created a true multidisciplinary and collaborative approach to learning, blending faculty and attendees from

vascular surgery, interventional cardiology, interventional radiology, vascular medicine, neurointervention/

neurosurgery, and cardiothoracic surgery. This year, VIVA welcomes our podiatric colleagues with a dedicated half-day

session and our cardiovascular healthcare professionals with a specialized three-day track.

VIVA is proud to assemble a faculty that challenges attendees to critically evaluate evolving trends and to remain

at the forefront of the vascular field, all with a spirit of collegiality and camaraderie. For 2012, VIVA plans to push

the envelope with topics and discussions in new and improved sessions such as The BLITZ, a case-based, fast-

paced educational experience; The Business of Health Care, featuring a renowned professor from Harvard Business

School; Strategies on the Frontline, the intense and wildly popular session that debuted in 2011; an expanded

International Forum offering even more global perspectives; and a session dedicated to what’s new in limb salvage.

With so many opportunities to learn, interact, and engage, attendees are guaranteed an amazing educational

experience. As one attendee stated, “if you haven’t been to VIVA lately, you haven’t been to VIVA!”

Please Join Us in October for the Premier Vascular Education Event of the Year!

3

L E A R N

I N T E R A C T

E N G A G E

CONTENTS

Continuing Medical Education

(CME) Credit Information …………………..... 4-5

The VIVA Experience ………………………..... 6-7

Special Events …………………………..……... 8-9

Session Descriptions ………………………. 10-15

Board Review Course …………………...... 10

Cardiovascular Healthcare Professionals .... 11

Monday Pre-Symposia ….....…………….... 12

Concurrent Sessions ………..…………. 13-15

VIVA 12 faculty ……………..……………… 16-18

Session Agendas ………..………………….. 19-35

Monday Pre-Symposia ……….……….. 19-21

General Session …………….…………. 22-29

Concurrent Sessions ………..…………. 30-35

Hotel Information …………………….……….. 36

Commercial Supporters & Exhibitors .……....... 37

Registration Information ………………….. 38-39

IMPORTANT DATES

Registration Pricing Schedule

Early Bird .…………….....……………. May 20 - July 31

Prime .…………….......…… August 1 - September 24

Standard .………………..… beginning September 25

New iPad App ..........……………......….. Available Now!

“face-Off” Abstract Submission Due Date …… July 15 See page 14 for details.

“face-Off” Notice of Acceptance …...……... August 17

On-Site Registration Opens ……..………….. October 6

CME Certificates Available …………..….… November 5

CONNECTLearn, engage, interact, and get connected with

VIVA all year long.

For weekly emails that you won’t want to miss, sign

up for the VIVA Weekly Dose!

www.VIVAPVD.com/email/Dose.aspx

4

EDUCATIONAL OBJECTIVESVIVA celebrates a decade of providing the leading multispecialty, collaborative education symposium with a

focus solely on peripheral vascular diseases.

We have remained true to our original goal of teaching those interested in providing the highest level of

patient care via an unbiased, comprehensive educational forum covering all aspects of vascular medicine

and intervention.

At the conclusion of the course, the targeted learners should be able to:

Understand the current indications, risks, complications, and long-term results of various medical therapies for the treatment of peripheral atherosclerotic vascular disease.

Increase knowledge in critical decision-making and the comprehensive spectrum of care for patients with foot ulcers and threatened limbs.

Increase awareness and understanding of the complete spectrum of interventional therapies for the treatment of patients with aortic complications.

Enhance understanding of venous physiology, anatomy, diseases and management options across a variety of venous territories.

Discuss the diagnosis and management of patients with thoracic aortic disease.

Increase knowledge of contemporary approaches to carotid artery management based on recent evidence-based data from randomized trials.

TARGET AUDIENCEVIVA will be of value to physicians, technologists, physician

assistants, nurse practitioners, and nurses who specialize in

interventional cardiology, interventional radiology, vascular

medicine, vascular surgery, cardiothoracic surgery, neurosurgery,

and neuroradiology. VIVA will also offer a new three-day session

designed specifically for cardiovascular healthcare professionals

(including nurses, vascular clinic staff, endovascular operating

room staff, interventional suite staff, nurse practitioners, vascular

technologists and physician assistants) who are interested in the

management of patients with vascular disease. VIVA also welcomes

our podiatric colleagues with a new pre-course session dedicated

to critical limb ischemia (CLI) and limb preservation.

CME INFORMATION

SEE WHAT’S NEW FOR 2012! www.VIVAPVD.com

CME ACCREDITATION This program has been planned and implemented in accordance with the Essential Areas and Policies of the

Accreditation Council for CME (ACCME) through joint sponsorship with the University at Buffalo School of Medicine

and Biomedical Sciences and VIVA Physicians. The University at Buffalo is accredited by the ACCME to sponsor

CME for physicians. The UB School of Medicine & Biomedical Sciences designates this live activity for a maximum

of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent

of their participation in the activity. Distribution of credits is as follows:

MONDAy: CLI and Limb Preservation: 4.0 Venous Interventions: 4.75 Cardiovascular Healthcare Professionals (CHPS): 7.0

TUESDAy: General Session and Chalk Talk/Dialog Session: 7.25 CHPS: 7.75

WEDNESDAy: General Session and Chalk Talk/Dialog Session: 7.25 CHPS: 7.25 International Forum: 4.0

ThURSDAy: General Session and Chalk Talk/Dialog Session: 7.25 International Forum: 8.0

FRIDAy: General Session: 3.75

PODIATRISTS: Affiliate sponsorship has been given by the American Podiatric Medical Association (APMA) for 4.0 hours of continuing medical education (CME) for Monday’s Critical Limb Ischemia (CLI) & Limb Preservation: A Multidisciplinary Approach symposium. An additional 4.25 contact hours can be earned for attending VIVA 12. Please see www.VIVAPVD.com for more details.

NURSES & TEChNOLOGISTS: CNE/CE credits for the Cardiovascular Health Professionals Symposium (CHPS) are available. Please see page 11 for details.

TO CLAIM CREDITS: Beginning November 5, 2012, attendees can log on to our website at www.VIVAPVD.com for information on how to claim educational credits. Detailed instructions can be found in the on-site registration booklet received at check-in.

5

DISCLAIMERThe information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

FACULTy DISCLOSUREUniversity of Buffalo at SUNY, in accordance with ACCME Accreditation requirements, requires faculty to disclose any financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed during this educational activity and with any commercial supporters of the activity.

UNLABELED PRODUCTS AND/OR PROCEDURES Faculty at this symposium may discuss information about pharmaceutical agents and/or devices and/or procedures that are outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications, devices and procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

COMMERCIAL FUNDING AND FINANCIAL SUPPORTVIVA 12 is funded by educational grants from various commercial organizations that have no control over program content. See page 37 for a current list of commercial supporters and contributors. A complete list of VIVA 12 supporters and exhibitors will be available on-site and at www.VIVAPVD.com.

6

THE VIVA EXPERIENCE

If you haven’t been to VIVA lately, you haven’t been to VIVA! Over the past decade, VIVA has stayed true to

its educational mission and has continuously offered the most current and effective medical information to the

vascular community. With a goal of providing the most cutting-edge and innovative learning modalities, VIVA has

enhanced the learning experience to be interactive, thought-provoking, and state-of-the-art.

See what VIVA has to offer:

LAPTOP LEARNING™

Laptop Learning™ is the groundbreaking educational system developed by VIVA in 2003 that integrates a variety of

media into an innovative and customizable learning program. It creates an educational platform that engages the

participant at his or her current skill/knowledge level and helps target specific learning needs. Laptop Learning™ offers

participants secure, private interaction with faculty in real-time, as well as the opportunity to take electronic notes, view

extended coverage of live cases, engage in live interactive polling with colleagues, and more. Many meetings have

attempted to garner the strength of electronic interaction, but none have matched the power of the Laptop Learning™

system. Laptop Learning™ is more than downloading presentations—it is the new way to learn, at your own pace, with

real-time interactivity between the participant and faculty experts. This state-of-the-art, interactive learning tool offers a

variety of features, including:

Live “Ask the Faculty” computer interface Slide presentations available 24/7 The ability to take electronic notes and save them to your USB drive A robust search engine of published vascular medicine literature Cath-Cam live-case streaming video* Interactive electronic job board Interactive polling Individualized self-assessment tools Course and speaker evaluations

Instant access to Coding and Billing sheets for all live cases

* Participants interested in more live case time than agenda constraints allow, can view extended live coverage from the laptops. Archived material from the symposium, including case studies and full presentations, will be available online at www.VIVAPVD.com after the program.

7

SPECIAL OPPORTUNITy TO LEARN IN 3d!VIVA’s determination to provide cutting-edge and innovative learning tools reached a new level in

2011 with the success of the evening premiere of vascular procedures shown in 3D. For VIVA 12,

this novel 3D educational tool will be available to every attendee in the General Session! Before each live case

demonstration, attendees will see a brief case in 3D offering interactive instruction and an enhanced perspective.

The 3D learning is sure to stimulate your senses and provide an unparalleled educational experience.

LIVE CASE SITES AND hOSTING PhySICIANSVIVA will transmit live cases from six leading vascular centers across the United States and Leipzig, Germany.

Based on the tenet of optimal patient care, the live case sites present a truly multidisciplinary approach to

endovascular therapy. These cases will give attendees the opportunity to observe optimal techniques and learn

practical tips performed live and in real-time. Patients will be enrolled in numerous multi-center, cutting-edge

clinical research trials to complement the on-site didactic lecture series.

VIVA 12 is proud to host live case demonstrations from the following sites:

ChALK TALK & DIALOG SESSIONS These concurrent sessions provide a myriad of topics with focused instruction by the leading experts. Space is

limited to first-come, first-served.

Chalk Talks – Rapid paced, purely technical sessions providing 45-minute interactive instruction with VIVA

faculty on specific aspects of vascular medicine and intervention.

Dialog Sessions – One-hour sessions providing an exclusive, intimate opportunity for participants to discuss a

specific topic with VIVA faculty in greater depth than what can be covered in a large symposium. The session

will consist of a brief presentation by a VIVA faculty member, followed by 40 minutes of questions and answers,

discussion of case examples, and a review of current standards of care.

LATE-BREAKING DATA…A dOUBLE dOSE!

Wednesday and Thursday at 1:20 pm in the General Session

Don’t miss these highly anticipated presentations of late-breaking clinical trial data. You will have two special

opportunities to access results from several major trials as they are discussed by a multispecialty group of panelists.

This is the latest trial data that may change your practice!

ohIo hEALTh/RIVERSIDE METhoDIST hoSPITAL COLUMBUS, OHIO GARy AnSEL, MD Interventional Cardiology

PRESByTERIAn hEART InSTITUTE DALLAS, TEXAS Tony DAS, MD Interventional Cardiology

EL CAMIno hoSPITAL MOUNTAIN VIEW, CALIFORNIA JAMES JoyE, Do Interventional Cardiology MIChAEL DAkE, MD Interventional Radiology

hoLy nAME MEDICAL CEnTER TEANECK, NEW JERSEY John RUnDBACk, MD Interventional Radiology

PARk hoSPITAL LEIPZIG LEIPZIG, GERMANY AnDREJ SChMIDT, MD Angiology

hAWAII PERMAnEnTE MEDICAL GRoUPkAISER FoUnDATIon hoSPITAL HONOLULU, HAWAII PETER SChnEIDER, MD Vascular Surgery

InTRo In

8

SPECIAL EVENTS

GOVERNMENT SUMMIT Wednesday, October 10 at 12:00 pm in Mouton 1

VIVA 12 continues the tradition of collaborating with leaders from the United States Food and Drug Administration

(FDA) and the Centers for Medicare and Medicaid Services (CMS) in our “Government Summit.” In the past,

we have highlighted emerging technologies and evaluated challenges and opportunities from the perspective

of our colleagues in the FDA and CMS. This year, for the first time and in keeping with the expanded involvement

of our international colleagues, leading representatives from the Japanese Pharmaceuticals and Medical

Devices Agency (PMDA) will join us. We will compare and contrast regulatory policies and practices and

highlight how collaboration has led the way to novel trials, which may result in multinational device approval.

Opinions on approaches to drug-coated balloons, renal denervation, and management of critical limb ischemia

will be discussed.

ThE VIVA ATLAS AWARD: “A TeACheR, LeAdeR, And SCholAR”

The VIVA ATLAS award is a distinction bestowed upon an extraordinary individual who has demonstrated leadership, mentorship, and scholarly activity that has profoundly affected the care of patients with vascular disease. VIVA is proud to recognize John A. Spittell Jr., MD as the recipient of this year’s prestigious award.

ThE VIVA ATLAS AWARD PRESENTATION – JOhN A. SPITTELL JR., MD

Thursday 8:40 am in the General Session

John Spittell Jr., MD (known as “Jack” by his admirers and friends alike) is the 2012

recipient of the VIVA ATLAS award. Since the ATLAS award is given to those giants in

the field of vascular medicine and intervention who have transformed our ability to care for patients through

teaching and scholarly activity, there is no one more deserving than Dr. Spittell. After completing his medical

school training at the University of Maryland, he was a captain in the U.S. Army Medical Corps, and subsequent

to that, completed an internal medicine residency at the Mayo Clinic Foundation. In 1961, he became the

head of the section of Peripheral Vascular Diseases at Mayo Clinic, and since then, has held multiple national

positions in esteemed organizations, including Chair of the Board of Governors of the American College of

Physicians. Dr. Spittell has published extensively in the field of vascular medicine, teaching legions of housestaff

the importance of a comprehensive physical examination when determining the appropriate treatment for

patients with vascular disease. With his keen eye and wit, Dr. Spittell has shaped the field of vascular medicine

and intervention by bringing together all specialties to offer comprehensive care for patients with vascular

disease. Many will remember the incredible lectures delivered by Dr. Spittell at the American College of

Cardiology symposia, as well as his role as key faculty for the Isner Heart House symposia held in Washington,

DC every year. It is an honor to bestow the 2012 ATLAS award to Dr. Jack Spittell, the penultimate teacher,

leader, and scholar.

John A. Spittell Jr., Md

9

LIVE AWARD (LEAdER IN ENdOVASculAR EducATiON)

This year marks the eighth annual LIVE award presentation at VIVA. Recipients of this award have epitomized those vascular specialists who have dedicated their professional careers to educating students, post-graduate trainees, and peers in all aspects of vascular medicine and intervention.

Dr. Dake joins the following LIVE award recipients:

This year’s LIVE award recipient redefines the award. Michael D. Dake, MD is the Thelma and Henry Doelger

Professor in the department of Cardiothoracic Surgery at Stanford University. After graduating from Harvard

College and obtaining his MD degree at Baylor College of Medicine, Dr. Dake completed a residency in Internal

Medicine and fellowship in Pulmonary Medicine at Baylor, followed by a residency and fellowship in Radiology

and Interventional Radiology at the University of California, San Francisco. He is currently the director of the

Cath/Angio suites at Stanford University Medical Center.

Dr. Dake has trained over 100 fellows during his career and countless other practicing physicians. He has

published over 250 original manuscripts, and has received innumerable national and international scholarly

awards, most recently the 2012 Society for Interventional Radiology Foundation Leaders in Innovation Award.

Dr. Dake is one of the preeminent leaders in the field, and from his background, it is not at all surprising that he

has worked jointly with multiple specialties throughout his career. It is with this spirit of education, collaboration,

and innovation that we proudly recognize Dr. Michael Dake as this year’s LIVE award recipient.

Michael d. dake, Md

ThE ANNIVERSARy GALAWednesday, October 10 from 7-10pm @ Encore’s Club XS

Join us for VIVA’s 10th anniversary celebration! After a decade of premier vascular education, we invite you to relax and enjoy an evening full of celebration and surprises! Attendance to the Anniversary Gala is included in your conference registration fee.

Additional tickets will not be sold at the door and must be purchased during your registration process or at the VIVA registration desk no later than Wednesday at 7:00pm. Registered attendees are welcome to bring a guest for an additional $100 per person. Name badges are required for all attendees and guests, and all participants must be at least 21 years of age and show a valid ID upon admittance.

LIVE AWARD PRESENTATION – MIChAEL D. DAKE, MD

Wednesday 8:40 am in the General Session

2005 – Kenneth Rosenfield, MD Interventional Cardiology

2006 – Barry Katzen, MD Interventional Radiology

2007 – L. Nelson hopkins III, MD Neurosurgery

2008 – Edward Diethrich, MD Cardiovascular Surgery

2009 – Gary Ansel, MD Interventional Cardiology

2010 – Michael R. Jaff, DO Vascular Medicine

2011 – Mark Wholey, MD Interventional Radiology

VIVA proudly collaborates with the Society for Vascular Medicine (SVM) for the 3rd annual national Vascular and

Endovascular Board Review Course (VEBRC). This two-day program is jam-packed with information to assist physicians

preparing for the American Board of Vascular Medicine (ABVM) board certification examinations, and is for those who

want a detailed, intensive review course including both vascular and endovascular components.

In the spirit of providing the highest levels of education and science,

the VEBRC offers everything the participant will need in one location

with a dedicated faculty and a truly state-of-the-art review course:

• TWOFULLDAYS:Saturday,October6at1pmtoMonday,October8at12pm

• Aworld-renownedfaculty,selectedfortheirabilitytoconveythecurrentcriticalexaminationcomponents

• TWOsampleexamsandreviewofanswers,addressingtopicsforboththegeneralvascularandendovasculartestingareas

• VIVA’sLaptopLearning™module,allowingattendeestotakenotes,downloadmaterial,andinteractwithfacultyinreal-time,allviaaconference-providedlaptop

• Theabilitytoreviewallcoursepresentationsatanytimewithsyncedaudio,video,andPowerPointslidesbyutilizingVIVA’sInstantReplaysystem

Want to extend your knowledge? Stay for VIVA 12 – the 10th anniversary!

VASCULAR And EndOVASCULAR

BOARD REVIEW COURSE

FACULTY INCLUDES:

Gary Ansel, MDInterventional Cardiology

Jerry Bartholomew, MDVascular Medicine

Mark Bates, MDInterventional Cardiology

Joshua Beckman, MDVascular Medicine

Mark Burket, MDInterventional Cardiology

John Campbell, MDVascular Medicine

Tony Das, MDInterventional Cardiology

Steven Dean, DOVascular Medicine

Douglas Drachman, MDInterventional Cardiology

Heather Gornik, MDVascular Medicine

Bruce Gray, DOVascular Medicine

L. Nelson Hopkins III, MDNeurosurgery

Michael R. Jaff, DOVascular Medicine

John Kaufman, MDInterventional Radiology

Scott Kinlay, MBBS, PhDInterventional Cardiology

Raghu Kolluri, MDVascular Medicine

Christopher Kwolek, MDVascular Surgery

Robert McBane, MDVascular Medicine

Suman Rathbun, MDVascular Medicine

Kenneth Rosenfield, MDInterventional Cardiology

John Rundback, MDInterventional Radiology

Robert Schainfeld, DOVascular Medicine

Peter Schneider, MDVascular Surgery

Timothy Sullivan, MDVascular Surgery

Michael Wholey, MDInterventional Radiology

CMEACCREDITATION&DESIGNATION

Physicians: This program has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for CME (ACCME) through joint sponsorship with the University at Buffalo School of Medicine and Biomedical Sciences and VIVA Physicians.

The University at Buffalo is accredited by the ACCME to sponsor CME for physicians. The UB School of

Medicine & Biomedical Sciences designates this live

activity for a maximum of 15.25 AMA PRA Category

1 Credits™ with the following distribution:

Saturday(1:00pm–5:00pm): 3.75

Sunday(8:00am–5:00pm):7.5

Monday(8:00am–12:00pm):4.0

ABVMExamination: dates for the 2012 ABVM examination(s) are november 27-december 15. Please visit www.vascularboard.org for details. The deadline to apply is October 19.

VIVA & The Society for Vascular Medicine present:

OCTOBER 6-8, 2012WYNN LAS VEGAS

Foracompleteagendaandtoregister,pleasevisitwww.VIVAPVD.com

Scan this mobile barcode for more information.

10

October8-10,2012•WynnLasVegas

New Symposium at VIVA 12 – Created Just for Healthcare Professionals!

11

CMEACCREDITATION&DESIGNATION

Physicians: The University at Buffalo is accredited by the ACCME to sponsor CME for physicians. The UB School of Medicine & Biomedical Sciences designates this live activity for a maximum

of 22.0 AMA PRA Category 1 Credits™.

new for 2012 is VIVA’s three-day educational track dedicated to the cardiovascular

healthcare professional. All allied vascular professionals including nurses,

vascular clinic staff, endovascular operating room staff, cath lab/angio suite

staff, vascular technologists, nurse practitioners, and physician assistants

should consider attending this expanded course. A respected faculty will

provide presentations on a wide variety of interesting topics focusing on

peripheral arterial disease, venous disease, wound care, non-invasive vascular

testing, and emerging therapies in the cardiac catheterization laboratory.

Additionally, CHPS attendees will have the opportunity to view and discuss the

live cases, transmitted in real-time from the General Session.

Credits for healthcare professionals are also available. For details, please visit www.VIVAPVd.com/conference and select CHPS from the VIVA 12 Highlights menu.

Foracompleteagendaandtoregister,pleasevisitusatwww.VIVAPVD.com

FACULTY INCLUDES:

Joshua Beckman, MDVascular Medicine

Cindi Christensen, MSN, CVN, ARNP

Mark Creager, MD Vascular Medicine

Tony Das, MDInterventional Cardiology

David Dawson, MDVascular Surgery

Regina Deible, BSN

David Del Pizzo, MHA, RVT

Karen Fitzgerald, MSN,RN, NP, CVN

Kenneth Gorski, RN, RCIS

William Gray, MDInterventional Cardiology

Michael Guiry, MBA, RPA-C

Gail Hadley, RN, RVT

Michael R. Jaff, DOVascular Medicine

James Joye, DOInterventional Cardiology

John Kaufman, MDInterventional Radiology

Debra Kohlman-Trigoboff, ACNP-BC, CVN

John R. Laird Jr., MDInterventional Cardiology

Julie Logan, RN

Robert Lookstein, MDInterventional Radiology

Sean Lyden, MDVascular Surgery

Manish Mehta, MDVascular Surgery

D. Christopher Metzger, MDInterventional Cardiology

Richard Neville, MDVascular Surgery

Jeffrey Olin, DOVascular Medicine

Carolyn Robinson, MSN, RN, CANP

Kenneth Rosenfield, MDInterventional Cardiology

Mitchell Silver, DOInterventional Cardiology

John Steinberg, DPMPodiatric Surgery

Stephanie Yates, MSN

Scan this mobile barcode for more information.

Monday: 8:00am–5:00pm

Tuesday:8:00am–5:40pm

Wednesday:8:00am–5:30pm

PRE-SYMPOSIA SESSIOnS

VIVAPRE-SYMPOSIA–MONDAY,OCTOBER8,2012These sessions are included in VIVA tuition.

VENOUSINTERVENTIONS:LEGS,LUNGS,ANDNECk1:00 - 6:00 pm in Mouton 1

This course will provide a comprehensive look at some of the hot topics in venous interventions, one of

the fastest growing areas of vascular intervention. do you want to know which of your patients should get

pharmacomechanical thrombectomy for deep vein thrombosis, and how best to do this? Are you considering

interventions for massive PE? Is there a difference between RF and Laser for varicose veins? And lastly, what

about CCSVI - will you be doing this, or should you leave it to someone else?

See page 19 for detailed agenda and CME information.

CRITICALLIMBISChEMIA(CLI)&LIMBPRESERVATION 1:00 - 5:30 pm in Lafite 7

This new half-day session is specifically designed for podiatrists, vascular specialists, cardiovascular healthcare

and other medical professionals who care for patients with peripheral arterial disease (PAd). This symposium will focus on

patients with the most severe form of PAd, critical limb ischemia (CLI), and opportunities for limb preservation.

CLI is an under-recognized problem that is growing due to the increasingly aging population, diabetes,

preponderance of metabolic syndrome, and increasing number of chronic kidney disease patients. A dedicated,

multispecialty faculty will provide a basic and in-depth review of contemporary diagnostic, clinical, therapeutic,

and programmatic considerations for the care of patients with CLI.

The program goal is to provide insights and tactical information about the manifestations, diagnosis, and patient

care considerations for this population. didactic and case-based presentations will provide an opportunity for

extensive discussion and interaction with the faculty. See page 20 for detailed agenda and CME information.

ThEBUSINESSOFhEALThCARE1:00 - 5:00 pm in Petrus 2

VIVA 12, our 10th anniversary, is an important milestone. As the leading educator in the field of vascular medicine

and intervention, VIVA continues to integrate critical components to improve the vascular specialists’ ability to care

for patients. As public policy evolves and health care reform becomes a reality, physicians are challenged with a

new vernacular….CEd….ACO…PCC…AQC….

Where do vascular specialists fit in the new world order? What is the intersection between health care reform

evolution and the provider? What must physicians understand?

And how can this all be done in an ethical and appropriate environment? VIVA tackles these tough topics and

more with internationally recognized experts, industry leaders, physicians involved in the evolution of health care,

and invited guests, including a renowned professor from Harvard Business School!

See page 21 for detailed agenda. Continuing education credits are not available for this session.

12

• D e b a t e s • Q & A • P a n e l D i s c u s s i o n s

Come to hear your role, your responsibility, your opportunity!

NEWforPODIATRISTSSpecialRegistrationPrice!

13

THE BLITZ!

Tuesday,October9,8:55am-4:50pminMargaux 1

Join us for this fast-paced, no-huddle learning session featuring small group

speed teaching and case discussions. This session offers rapid presentations

from VIVA faculty at a variety of stations, each focused on a different vascular

topic. Attendees will have just eight minutes to engage an interesting case

before rotating to a new station with a different captivating topic.

VIVAVOCE[vocha]Tuesday,October9,8:55am-4:50pminMargaux 1

Watch LIVE as top physicians take the “hot seat” for a one-on-one interview with VIVA faculty. In this intimate session

of Q&A, interviewers will encourage a no-holds-barred dialog and provocative discussion of vascular headlines.

See page 30 for detailed agendas. Continuing education credits are not available for these sessions.

VIVACONCURRENTSESSIONS–TUESDAY-ThURSDAYThis year, VIVA has FOUR concurrent sessions, each offering something for every attendee! Attendance is included

in your tuition. See details below.

The Endovascular Equivalent of a “Speed Dating” Experience!

E N G A G E

COnCURREnT SESSIOnS

SEE WhAT’S NEW For 2012! www.VIVAPVD.com

L E A R N

I N T E R A C T

AbdominalAorta

Carotid /Stroke

IliacMesenteric /

Portal RenalSFA

ThoracicAorta

Tibial /Pedal

VenousTHE BLITZwillbedynamic,high-energy,andfast-paced.

Don’t get left behind!

Don’t Miss This! Sameroom,sametime...

14

COnCURREnT SESSIOnS

14

InternatIonal ForumWednesdayandThursday,October10 -11inLafleur 1 & 2

See pages 31-33 for detailed agenda and CME information.

This forum will provide an open airing of perspectives and a sharing of interventional experiences from leading

international sites, including panel and live case discussions with global authorities. This intense two-day

experience is designed to expand our knowledge of vascular practices worldwide via an open-minded environment

for an interactive exchange of ideas, methodologies, and practices. The world’s leading international vascular

care experts will discuss regional variations in the diagnosis and treatment of vascular pathologies, including

medical, endovascular, and surgical therapies.

Attendees will not only have intimate access to these international key opinion leaders, but will also learn from

the top six presenters selected from the Face-OffwithVIVAFaculty session, who will showcase their interesting

case or educational research to the entire audience. To enhance the inclusive and intimate nature of this course,

attendees in the International Forum will have the ability to actively participate, via a live audio and video feed,

with the General Session during live cases.

FACE-OFFWIThVIVAFACULTY8:55am-12:00pminMargaux 1

See page 31 for detailed agenda. Continuing education credits are not available for this session.

Before the official start of the International Forum, join us for this lightning round competition series featuring

a fast and furious showcase of presentations by vascular experts and trainees from across the globe.

International physicians and U.S. fellows will present original research or interesting cases with a focus on

complex procedures, complication management, advanced and novel techniques, diagnostic challenges,

and/or new technology. Participants will have seven minutes to present (in PowerPoint format) and three

minutes of Q&A as they are judged by VIVA faculty who are tasked with selecting six winners who will

present in the International Forum on Wednesday afternoon and Thursday. Three fellows will win the

new iPad and the top three international winners will be awarded a twoweek‘hands-on’vascularand

endovasculartrainingattheAlbanyVascularInternationalAcademy,TheInstituteforVascularhealth

&Disease@AlbanyMedicalCenterinNewYork.

For abstract submission instructions, visit www.VIVAPVD.com/conference and select “Face-Off with VIVA Faculty”

from the VIVA 12 Highlights menu.

CELEBrATING TEN YEArS oF VASCULAr EDUCATIoN!

WEDNESDAY, OCTOBER 10, 2012kick-offwithFACE-OFF!

Multi-Day Session!

15

For UpDATED proGrAM INForMATIoN VISITwww.VIVAPVD.com

WEDNESDAY, OCTOBER 10, 2012

THE ORIGINALSTRATEGIESONThEFRONTLINEWednesdayandThursday,October10 -11inMargaux 2 See pages 34-35 for detailed agenda.

Continuing education credits are not available for this session.

It’s never the wrong time to practice the basics while learning tips and pearls from the pros–and this year,

following a wildly popular response to its debut in 2011, VIVA offers a newly buffed training experience as

part of an intense two-day program designed to upgrade your procedural skills through tactical and

strategic sessions held in a no-nonsense situation room setting.

On Wednesday, enter ThePresentationBunker, where it’s a non-stop serving of cases, and nothing but

cases ALL dAY! Whether you choose to enlist in the whole tour or join for instruction focused on a

particular vascular territory, your hard-nosed drill leaders are determined to expand the boundaries of

your current understanding.

The Strategies sessions wrap up on Thursday when the council chamber becomes

ThehurtLocker, where the realities of complications are exposed and dissected by

expert vascular operatives who know only too well, the situation: Armageddon was

yesterday – today we have a serious problem.

Multi-Day Session!

The

SiTuaTion

room

16

GARY M. ANSEL, MDInterventional CardiologyRiverside Methodist HospitalColumbus, Ohio

JoShuA A. BEckMAN, MDVascular MedicineBrigham and Women’s HospitalBoston, Massachusetts

MIchAEL D. DAkE, MDInterventional RadiologyStanford University Medical CenterStanford, California

ToNY S. DAS, MDInterventional CardiologyPresbyterian Heart InstituteDallas, Texas

MIchAEL R. JAFF, DoVascular MedicineMassachusetts General HospitalBoston, Massachusetts

JAMES D. JoYE, DoInterventional CardiologyEl Camino HospitalMountain View, California

JohN A. kAuFMAN, MDInterventional RadiologyDotter Interventional InstitutePortland, Oregon

JohN R. LAIRD JR., MDInterventional CardiologyUC Davis Medical CenterSacramento, California SEAN P. LYDEN, MDVascular SurgeryCleveland ClinicCleveland, Ohio

MANISh MEhTA, MDVascular SurgeryThe Institute for Vascular Health and DiseaseAlbany, New York

kRIShNA RochA-SINGh, MDInterventional CardiologyPrairie Vascular InstituteSpringfield, Illinois

kENNETh RoSENFIELD, MDInterventional CardiologyMassachusetts General HospitalBoston, Massachusetts JohN h. RuNDBAck, MDInterventional RadiologyHoly Name HospitalTeaneck, New Jersey

PETER A. SchNEIDER, MDVascular SurgeryHawaii Permanente Medical GroupHonolulu, Hawaii

JohN FRITz ANGLE, MDInterventional RadiologyUniversity of Virginia Health SystemCharlottesville, Virginia

VINAY BADhwAR, MDCardiothoracic SurgeryUniversity of Pittsburgh Medical CenterPittsburgh, Pennsylvania

SuBhASh BANERJEE, MDInterventional CardiologyVA North Texas Health Care SystemDallas, Texas

JAMES BENENATI, MDInterventional RadiologyBaptist Cardiac & Vascular InstituteMiami, Florida

RoBERT BERSIN, MDInterventional CardiologySeattle CardiologySeattle, Washington

MARk BuRkET, MDInterventional CardiologyUniversity of Toledo Medical CenterToledo, Ohio

DANIEL G. cLAIR, MDVascular SurgeryCleveland ClinicCleveland, Ohio

MARk A. cREAGER, MDVascular MedicineBrigham and Women’s HospitalBoston, Massachusetts

R. cLEMENT DARLING, MDVascular SurgeryAlbany Medical Center HospitalAlbany, New York

SRIkANT DATAR, PhDHarvard Business SchoolBoston, Massachusetts

DAVID DAwSoN, MDVascular SurgeryUC Davis Vascular CenterSacramento, California

DAVID huGo DEAToN, MDVascular SurgeryGeorgetown University HospitalWashington, DC

coLIN DERDEYN, MDNeuroradiologyBarnes Jewish HospitalSt. Louis, Missouri

MATThEw EAGLEToN, MDVascular SurgeryCleveland ClinicCleveland, Ohio

MARk ESkANDARI, MDVascular SurgeryNorthwestern Memorial HospitalChicago, Illinois

MARk FARBER, MDVascular SurgeryUNC HospitalsChapel Hill, North Carolina

MIchAEL FISchBEIN, MDCardiothoracic SurgeryStanford Hospital and ClinicsStanford, California

LAwRENcE GARcIA, MDInterventional CardiologySt. Elizabeth’s Medical CenterBoston, Massachusetts

FACULTY

VIVA Steering Committee

Faculty

17

hEAThER L. GoRNIk, MDVascular MedicineCleveland ClinicCleveland, Ohio

BRucE GRAY, DoVascular MedicineGreenville Memorial HospitalGreenville, South Carolina

wILLIAM GRAY, MDInterventional CardiologyNew York Presbyterian Medical CenterNew York, New York

LANFRoI GRAzIANI, MDInterventional CardiologyIstituto Clinico Città di Brescia HospitalBrescia, Italy

zIV J. hASkAL, MDInterventional RadiologyUniversity of Maryland School of MedicineBaltimore, Maryland

L. NELSoN hoPkINS III, MDNeurosurgeryMillard Fillmore Gates HospitalBuffalo, New York

wILLIAM D. JoRDAN JR., MDVascular SurgeryThe Kirklin ClinicBirmingham, Alabama

STEPhEN kEE, MDInterventional RadiologyUCLA Medical SchoolLos Angeles, California

zVoNIMIR kRAJcER, MDInterventional CardiologyTexas Heart Institute at St. Luke’s Episcopal HospitalHouston, Texas

chRISToPhER kwoLEk, MDVascular SurgeryMassachusetts General HospitalBoston, Massachusetts

JASoN T. LEE, MDVascular SurgeryStanford University Medical CenterStanford, California

MARTIN LEoN, MDInterventional CardiologyColumbia University Medical CenterNew York, New York

RoBERT LookSTEIN, MDInterventional RadiologyMount Sinai Medical CenterNew York, New York

GEoFFREY RuBIN, MDCardiovascular RadiologyDuke University Medical CenterDurham, North Carolina

RIchARD SAxoN, MDInterventional RadiologyNorth County RadiologyEncinitas, California

DIERk SchEINERT, MDAngiologyPark Hospital LeipzigLeipzig, Germany

GARY SISkIN, MDInterventional RadiologyAlbany Medical Center HospitalAlbany, New York

BENJAMIN w. STARNES, MDVascular SurgeryHarborview Medical CenterSeattle, Washington

TIMoThY SuLLIVAN, MDVascular SurgeryAbbott Northwestern HospitalMinneapolis, Minnesota

ThoRALF SuNDT III, MDCardiothoracic Vascular SurgeryMassachusetts General HospitalBoston, Massachusetts

ThoMAS T. TSAI, MDInterventional CardiologyDenver VA Medical CenterDenver, Colorado

SuRESh VEDANThAM, MDInterventional RadiologyMallinckrodt Institute of RadiologySt. Louis, Missouri

FRANk J. VEITh, MDVascular SurgeryCleveland Clinic/New York UniversityCleveland, Ohio/New York, New York

ERIc VERhoEVEN, MD, PhDVascular SurgeryKlinikum NürnbergNürnberg, Germany

EDwARD Y. woo, MDVascular SurgeryUniversity of PennsylvaniaPhiladelphia, Pennsylvania

ThoMAS zELLER, MDAngiologyHerz-Zentrum, Bad KrozingenBad Krozingen, Germany

ALAN B. LuMSDEN, MDVascular SurgeryMethodist DeBakey Heart & Vascular CenterHouston, Texas

RAJ MAkkAR, MDInterventional CardiologyCedars-Sinai Medical CenterLos Angeles, California

ALAN h. MATSuMoTo, MDInterventional RadiologyUniversity of Virginia Health SystemCharlottesville, Virginia

JoN MATSuMuRA, MDVascular SurgeryUniversity of Wisconsin Hospitals and ClinicsMadison, Wisconsin

D. chRISToPhER METzGER, MDInterventional CardiologyWellmont CVA Heart InstituteKingsport, Tennessee

JIhAD A. MuSTAPhA, MDInterventional CardiologyMetro Health HospitalWyoming, Michigan

RIchARD NEVILLE, MDVascular SurgeryGeorge Washington University HospitalWashington, DC

GuSTAVo oDERIch, MDVascular SurgeryMayo ClinicRochester, Minnesota

JEFFREY w. oLIN, DoVascular MedicineMount Sinai Medical CenterNew York, New York

coNSTANTINo PEñA, MDInterventional RadiologyBaptist Cardiac & Vascular InstituteMiami, Florida

ALIcE PERLowSkI, MDInterventional CardiologyChicago, Illinois

MAhMooD RAzAVI, MDInterventional RadiologySt. Joseph Heart and Vascular CenterOrange, California

ScoTT RESNIck, MDInterventional RadiologyNorthwestern Memorial HospitalChicago, Illinois

ANNE RoBERTS, MDInterventional RadiologyThornton Hospital/UCSD Medical CenterLa Jolla, California

18

FACULTY

International Forum Faculty

RoBERTo BEck, MDInterventional RadiologyDona Helena HospitalSanta Catarina, Brazil

VARINDER BEDI, MDVascular SurgeryArmy Hospital R & R, Delhi CanttNew Delhi, India

JAcquES BuSquET, MDVascular SurgeryClinique Chirurgicale Val d’Or - Foch Foundation GroupParis, France

NIck JohN chEShIRE, MDVascular SurgerySt. Marys HospitalLondon, United Kingdom

AuGuSTIN JAMES DELAGo, MDInterventional CardiologyAlbany Medical Center HospitalNew York, USA

koEN DELooSE, MDVascular SurgerySint Blasius HospitalFlanders, Belgium

wALTER DoRIGo, MDVascular SurgeryCareggi HospitalFlorence, Italy

MARcELo FERREIRA, MDVascular SurgerySITE Medical Services Rio de Janeiro, Brazil

DAISukE FukuI, MD, PhDCardiovascular SurgeryShinshu University School of MedicineNagano, Japan

RoGER M. GREENhALGh, MDVascular SurgeryCharing Cross HospitalLondon, United Kingdom wEI Guo, MDVascular SurgeryChinese PLA General HospitalBeijing, China

ANDREw hoLDEN, MDInterventional RadiologyAuckland HospitalAuckland, New Zealand

ARMANDo LoBATo, MDVascular SurgerySão Paulo Vascular & EndovascularSurgery InstituteSão Paulo, Brazil

SuMAIRA MAcDoNALD, MDInterventional RadiologyFreeman HospitalNewcastle upon Tyne, United Kingdom

MARco MANzI, MDInterventional RadiologyPoliclinico Abano Terme Abano Terme, Italy

FRANS MoLL, MD, PhDVascular SurgeryUniversity Medical Center UtrechtUtrecht, The Netherlands

PANkAJ PATEL, MBBSVascular SurgeryLilavati Hospital and Research CenterMumbai, India VINcENT RIAMBAu, MD, PhDVascular SurgeryHospital ClinicBarcelona, Spain RoBERTo SAcILoTTo, PhDVascular SurgeryHospital do Servidor Publico Estadual de São PauloSão Paulo, Brazil

FERDINAND SERRAcINo-INGLoTT, MDVascular SurgeryManchester Royal InfirmaryManchester, United Kingdom

PIERRE GALVAGNI SILVEIRA, MD, PhDVascular SurgeryUniversidade Federal de Santa CatarinaSanta Catarina, Brazil

PETER RIchARD TAYLoR, MDVascular SurgeryGuy’s & St Thomas’ NHS Foundation TrustLondon, United Kingdom

hENcE J. VERhAGEN, MDVascular SurgeryErasmus University Medical CenterRotterdam, The Netherlands

19

The following Monday pre-symposia sessions are included in your tuition.

SEE WHAT’S NEW FOR 2012! www.VIVAPVD.com

MONDAY, OCTOBER 8, 2012 • AGENDA

VENOUS INTERVENTIONS: LEGS, LUNGS, AND NECK 1:00 – 6:00 pm in Mouton 1

This course will address the hot topics in venous interventions. Please see page 12 for full course description.

This session is accredited for 4.75 CME credits.

The New Anticoagulants That You Need to Know About Joshua Beckman, MD

Imaging Acute and Chronic VTE constantino Peña, MD

Tools of the Trade: What Works for Acute DVT Mahmood Razavi, MD

Tools of the Trade: What Works for Chronic DVT christopher kwolek, MD

DVT Intervention Trials and Guidelines Update Suresh Vedantham, MD

IVC FIlter PoInt-CounterPoInt

IVC Filters are Mandatory During Interventions for Acute Iliofemoral DVT Alan Lumsden, MD

IVC Filters are NOT Mandatory During Interventions for Acute Iliofemoral DVT Scott Resnick, MD

GRILL THE SPEAKERS: Q&AModerator: John kaufman, MD Panel: Joshua Beckman, MD; christopher kwolek, MD; Alan Lumsden, MD; constantino Peña, MD; Mahmood Razavi, MD; Scott Resnick, MD; Suresh Vedantham, MD

REFRESHMENT BREAK

How to Get IVC Filters Out John kaufman, MD

Massive PE Interventions kenneth Rosenfield, MD

Submassive PE: When to Intervene and How Scott Resnick, MD

PANEL DISCUSSION/Q&A Moderator: John kaufman, MD Panel: Scott Resnick, MD; kenneth Rosenfield, MD

Chronic Venous Insufficiency: Who to Treat Robert Lookstein, MD

Endovenous Ablation Technologies: Is There Really a Difference? John kaufman, MD

What We Need to Learn About CCSVI Manish Mehta, MD

CCSVI Intervention: What it Really Takes to Offer This Gary Siskin, MD

OPEN FORUM: Q&AModerator: John kaufman, MD Panel: Robert Lookstein, MD; Manish Mehta, MD; Scott Resnick, MD; Gary Siskin, MD

1:00 - 1:20 pm

1:20 - 1:40 pm

1:40 - 2:00 pm

2:00 - 2:20 pm

2:20 - 2:40 pm

2:40 - 2:50 pm

2:50 - 3:00 pm

3:00 - 3:05 pm

3:05 - 3:20 pm

3:20 - 3:40 pm

3:40 - 4:00 pm

4:00 - 4:20 pm

4:20 - 4:40 pm

4:40 - 5:00 pm

5:00 - 5:20 pm

5:20 - 5:40 pm

5:40 - 6:00 pm

6:00 pm

NEW!NEW!

PRE-SYMPoSIA

ThroughouT The Course:• D e b a t e s • Q & A s e s s i o n s• P a n e l D i s c u s s i o n s

20

CRITICAL LIMB ISCHEMIA (CLI) & LIMB PRESERVATION: A MULTIDISCIPLINARY APPROACH 1:00 – 5:30 pm in Lafite 7

A new session specifically designed for those who care for patients with PAD, including the most severe form

of this disease, CLI. Please see page 12 for full course description. This session is accredited for 4.0 CME credits

and 4.0 CME contact hours through the APMA.

Course Introduction Richard Neville, MD; John Rundback, MD

DIAGnoStIC ASSeSSMent oF ClI

How Extensive is the Problem and What are the Implications for Our Health Care System Tony Das, MD

The “Up-to-Date” Vascular Lab - Basic Testing to Assure Success in the Limb Salvage World heather Gornik, MD

Assessing Perfusion in the Foot: Techniques and Implications for Revascularization Mark creager, MD

Cross-Sectional Imaging of the Threatened Limb: What to Order, When to Order it, and Why it is Important Robert Lookstein, MD

nAVIGAtInG tHe “BeloW Knee” ArterIAl tree

Normal and Variant Calf and Pedal Arterial Anatomy - Understanding Angiosomes and Their Relevance for Treatment Marco Manzi, MD

Endovascular Revascularization for Limb Preservation: Basic Techniques John Laird, MD

Endovascular Revascularization for Limb Preservation: Advanced Techniques John Rundback, MD

A Brave, New World: Plantar-Pedal Loop Techniques Lanfroi Graziani, MD

What is the Role of the Interventionalist (IC/IR/VS) in a Limb Preservation Program? Sean Lyden, MD

Case Reviews John Rundback, MD

REFREShMENT BREAk

WounD CAre AnD tHe SurGeon

Surgical Bypass for Limb Preservation; Sometimes It’s Still the Right Thing Richard Neville, MD

Prosthetic Conduit for Limb Preservation; the International Experience walter Dorigo, MD

The Microbiology of Wound Care; How Do We Fight Infection and Does Biofilm Really Matter?christopher Attinger, MD

Achieving Closure and Healing - Management of Wound Healing from Debridement to BiotechJohn Steinberg, DPM

Advanced Plastic and Surgical Techniques for Healing Challenging Wounds Frank Tursi, DPM

Case Reviews Richard Neville, MD

1:00 - 1:05 pm

1:05 - 1:15 pm

1:15 - 1:25 pm

1:25 - 1:35 pm

1:35 - 1:45 pm

1:45 - 1:55 pm

1:55 - 2:05 pm

2:05 - 2:15 pm

2:15 - 2:25 pm

2:25 - 2:35 pm

2:35 - 3:05 pm

3:05 - 3:30 pm

3:30 - 3:40 pm

3:40 - 3:50 pm

3:50 - 4:00 pm

4:00 - 4:10 pm

4:10 - 4:20 pm

4:20 - 4:50 pm

Agenda subject to change.

MONDAY, OCTOBER 8, 2012 • PRE-SYMPOSIA

NEW for PODIATRISTSSpecial Registration Price!

Continued

21

CreAtInG A HeAlInG enVIronMent - ProGrAM DeVeloPMent

How to Build a Limb Preservation Program; Assembling the Pieces Richard Neville, MD

PANEL DISCUSSION: Limb Preservation ProgramsModerator: John Rundback, MD Panel: Mark creager, MD; Lanfroi Graziani, MD; Richard Neville, MD; John Steinberg, DPM; Frank Tursi, DPM

Adjourn

Welcome and Introductions Michael R. Jaff, Do

The Challenges and Opportunities of Health Care Reform on Hospitals - Big, Medium, and SmallAnn Prestipino, MPh

The Challenges of Health Care Reform on the Medical Device Industry; Current and FutureStacy Enxing Seng, MBA

A CASE STUDY FOR VASCULAR SPECIALISTS Instructor: Michael R. Jaff, Do Panel: Michael Dake, MD; Stacy Enxing Seng, MBA; Robert hopkins; Louis Jacques, MD; Ann Prestipino, MPh; kenneth Rosenfield, MD; Gwen watanabe, MSME, MBA

REFREShMENT BREAk

CMS and Health Care Reform - Insights from the Front Lines Louis Jacques, MD

Financial Markets and Health Care Reform - Clashes and Opportunities Robert hopkins

Perspectives on the U.S. Health Care Scene from a Harvard Business School Professor Srikant Datar, PhD

PANEL DISCUSSION/Q&A Moderator: Michael R. Jaff, Do Panel: Michael Dake, MD; Stacy Enxing Seng, MBA; Robert hopkins; Louis Jacques, MD; Tamara Syrek Jensen, JD; Ann Prestipino, MPh

Symposium Concludes

4:50 - 5:00 pm

5:00 - 5:30 pm

5:30 pm

1:00 - 1:10 pm

1:10 - 1:30 pm

1:30 - 1:50 pm

1:50 - 2:50 pm

2:50 - 3:15 pm

3:15 - 3:40 pm

3:40 - 4:00 pm

4:00 - 4:30 pm

4:30 - 5:00 pm

5:00 pm

THE BUSINESS OF HEALTH CARE 1:00 – 5:00 pm in Petrus 2

A course addressing the role of vascular specialists in public policy and health care reform. Included in this session

is an in-depth discussion of a fictional case, available for participants to download and review at www.VIVAPVD.com.

Please see page 12 for full course description. Continuing education credits are not available for this session.

INVITED GuESTS:

Srikant Datar, PhDHarvard Business School

Stacy Enxing Seng, MBACovidien

Robert hopkinsBanc of America Securities Merril Lynch

Louis Jacques, MDCenters for Medicare & Medicaid Services

Tamara Syrek Jensen, JDCenters for Medicare & Medicaid Services

Ann Prestipino, MPhMassachusetts General Hospital

Gwen watanabe, MSME, MBAHotspur Technologies, Inc.

Come to hear your role,your responsibility,your opportunity!

22

TUESDAY, OCTOBER 9, 2012 • DAY 1VIVA 12 AGENDA

Agenda subject to change.

Welcome to VIVA 12! Tony Das, MD

BIG PICTURE ISSUE: ThE FUTURE oF SFA TEChnoloGy And EndovASCUlAR TREATmEnT - WhAT doES IT look lIkE In 5 yEARS?

When Will We Use Bare Stents and Will New Stent Designs Provide Better Results and Value? D. Christopher Metzger, MD

CHALK TALK

Will Endoluminal Bypass with Stent-Grafts Become the Default Therapy for Long Lesions and Extensive Disease – What’s Necessary to Make This Happen? Richard Saxon, MD

How Often Will We Use Drug-Eluting Stents – What Patients/Lesions Will be the Most Likely to Benefit? Michael Dake, MD

Will Drug-Coated Balloons be the Next Workhorse Technology and What are the Anticipated Practical Limitations? Tony Das, MD

LIVE CASE DEMONSTRATIONS: Ohio Health/Riverside Methodist HospitalModerator: Tony Das, MDPanel: Bruce Gray, DO; Martin Leon, MD; Marco Manzi, MD;Richard Neville, MD; Constantino Peña, MD; Gary Siskin, MD

Is There a Role for Spot-Tacking of PTA/DCB Dissection Failures to Avoid Stent Placement – is This a Viable Hybrid Solution? David Deaton, MD

Will the Advantages of Percutaneous Extraluminal Bypass Make it in Everyday Procedure in 5 Years Alan Lumsden, MD

Are Bioresorbable Vascular Scaffolds Really Necessary – Will They Get Approved, at What Cost, and When? Robert Bersin, MD

10th ANNIVERSARY KEYNOTE ADDRESS: Moral and Ethical Expectations of Leaders Srikant Datar, PhD

REFRESHMENT BREAK

When My “Go-To” Therapy is Not the Right Choice:

When Not to Do Carotid Endarterectomy Daniel Clair, MDWhen Carotid Artery Stent Placement is a Mistake William Gray, MDWhen Best Medical Therapy is Not Appropriate Heather Gornik, MD

LIVE CASE DEMONSTRATIONS: Ohio Health/Riverside Methodist Hospital and El Camino HospitalModerator: Joshua Beckman, MDPanel: Vinay Badhwar, MD; James Benenati, MD; Mark Burket, MD; Christopher Kwolek, MD; Jeffrey Olin, DO; Suresh Vedantham, MD

LUNCH / SATELLITE SYMPOSIA

ThoRACIC AoRTA

CURRENT PRACTICE - ASSESSING YOUR PATIENT: How I Analyze Acute Aortic Dissection and Symptomatic Aortic Intramural Hematoma: What’s Needed to Develop a Management Plan John Kaufman, MD

8:00 - 8:05 am

8:05 - 8:12 am

8:10 - 8:55 am

8:12 - 8:19 am

8:19 - 8:26 am

8:26 - 8:33 am

8:33 - 9:32 am

9:32 - 9:39 am

9:39 - 9:46 am

9:46 - 9:53 am

9:53 - 10:10 am

10:10 - 10:40 am

10:40 -11:01 am

11:01 am - 12:00 pm

12:00 - 1:20 pm

1:20 - 1:28 pm

8:10 - 8:55 am

Chalk TalkHow I Blend Imaging, Laboratory Exams, and Clinical Evaluation to Diagnose and Manage VasculitidesModerator: Michael R. Jaff, DOPanel: Mark Creager, MD; Heather Gornik, MD; Sumaira Macdonald, MD; Jeffrey Olin, DO

Located in Alsace 1

INTRO IN

INTRO IN

JOIN US FOR A VIVA 12 CONCURRENT SESSION!

v

8:55 am - 4:50 pm

THE BLITZ!Small group speed teaching, fast-paced case discussions, and rapid presentations from VIVA faculty at various vascular stations.

Located in Margaux 1 See page 30 for agenda.

v

8:55 am - 4:50 pm

VIVa VOCE [vo cha]Top physicians take the “hot seat” to dicuss vascular headlines with VIVA faculty.

Located in Margaux 1 See page 30 for agenda.

23

Uncomplicated Type B Aortic Dissection – Do We Currently Know Who Benefits from a More Aggressive Approach and Should We be Parsing Patients into More Detailed Subgroups? Edward Woo, MD

Why I Do What I Do: a Decision Support analysis for Chronic Type B Dissection with aneurysm Formation:

Open Surgery is the Best Treatment Because It’s Definitive Thoralf Sundt, MD

TEVAR with or without Adjunctive Endovascular Maneuvers is Less Risky and Just as Protective as Operative Repair Benjamin Starnes, MD

The Spectrum of Adjunctive Endovascular Techniques to Promote False Lumen Thrombosis After TEVAR for Aortic Dissection – Why This is an Important Goal Manish Mehta, MD

LIVE CASE DEMONSTRATIONS: Ohio Health/Riverside Methodist Hospital and El Camino HospitalModerator: Manish Mehta, MDPanel: Lawrence Garcia, MD; Robert Lookstein, MD; Alan Lumsden, MD; Alice Perlowski, MD; Dierk Scheinert, MD

DEBATE: Snorkels, Chimneys, Periscopes, and Sandwiches are Now Main Stream, Well-Established Techniques to Expand TEVAR/EVAR Applications

Nonsense, These are Only Temporary Place Holders; Gimmicks that Should be Reserved Only for Bail-Outs Because They are Doomed to Fail if Used in Inadequate Aortic Necks Christopher Kwolek, MD

Without a Doubt, These are Positive Adjuncts that Allow Us to Successfully Deliver Endovascular Treatment to more Extensive Aortic Disease – These Valuable Techniques are Here to Stay Jason Lee, MD

REFRESHMENT BREAK

CARdIAC/STRUCTURAl hEART

DIALOG SESSION

Minimally Invasive Open Approaches to Cardiac Valve Repair and Replacement: How and Why I Do It Vinay Badhwar, MD

CURRENT PRACTICE - ASSESSING YOUR PATIENT: Selecting the Right Patients for TAVI Martin Leon, MD

DEBATE: My Preferred Approach to TAVR is Best for Patients Because...

Trans-Apical Delivery is Easier and Has Better Outcomes With Less Stroke Michael Fischbein, MD

Trans-Femoral Introduction is Less Invasive, Simpler, and Has Less Morbidity Raj Makkar, MD

Nontraditional Access Routes to the Aortic Valve are Frequently the Best Choice Timothy Sullivan, MD

LIVE CASE DEMONSTRATIONS: El Camino HospitalModerator: John Laird, MDPanel: Fritz Angle, MD; David Deaton, MD; Lanfroi Graziani, MD; Louis Jacques, MD; Mahmood Razavi, MD; Benjamin Starnes, MD

DAY ONE CONCLUDES / SATELLITE SYMPOSIA

1:28 - 1:36 pm

1:36 - 1:57 pm

1:57 - 3:06 pm

3:06 - 3:20 pm

3:20 - 3:50 pm

3:50 - 4:50 pm

3:50 - 3:57 pm

3:57 - 4:04 pm

4:04 - 4:25 pm

4:25 - 5:40 pm

5:40 pm

3:50 - 4:50 pm DIalOG SESSIONThe Spectrum of Metabolic and Connective Tissue Diseases that Affect the Aorta; What You Need to KnowModerator: Sean Lyden, MDPanel: Michael R. Jaff, DO; Christopher Kwolek, MD; Alan Lumsden, MD; Constantino Peña, MDLocated in Alsace 1

INTRO IN

INTRO IN

CONCURRENT SESSIONS...Continued

vVIVa VOCE [vo cha]

Located in Margaux 1See page 30 for agenda.

vTHE BLITZ!Located in Margaux 1 See page 30 for agenda.

Satellite Symposia

Review of Tuesday’s Live Cases Gary Ansel, MD

REnAl/hyPERTEnSIon/mESEnTERIC

What’s the Future of Renal Artery Stenting – Is It a Historical Relic or Will New Studies Dust It Off and Get It Off the Shelf? Michael R. Jaff, DO

How do We Get Our Head Around Renal Denervation for Hypertension – How Big is It, Who Gets Treated, What Can We Expect? Mark Burket, MD

Alternatives to RF Renal Nerve Ablation – Do Fast Followers Have Something Better to Offer? Krishna Rocha-Singh, MD

SPECIAL FEATURE – THIS IS HOW I DO IT: My Strategy for Managing Renal and Visceral Aneurysms: Assessment, Planning, Techniques, Procedural Decisions Fritz Angle, MD

LIVE AWARD PRESENTATION (leader In EndoVascular Education)Honoring Michael Dake, MD for his contribution to endovascular education and patient care. Presented by Michael R. Jaff, DO

LIVE CASE DEMONSTRATIONS: Holy Name HospitalModerator: Michael R. Jaff, DOPanel: Clement Darling, MD; Louis Jacques, MD; Jason Lee, MD; D. Christopher Metzger, MD; Scott Resnick, MD; Timothy Sullivan, MD

CHALK TALK

vASCUlAR dIAGnoSIS

CURRENT PRACTICE – ASSESSING YOUR PATIENT: Vascular Disease in Young Adults – What Should I be Thinking and More Importantly, Doing to Diagnose and Treat? Mark Creager, MD

The Current Status of Bone Marrow-Derived Stem Cell Therapies for CLI: When is It Appropriate, How is It Done, and What Should We Expect? Jeffrey Olin, DO

Molecular Imaging of Vascular Disease Now and in the Future: What Should We Expect and What Will It Contribute? Geoffrey Rubin, MD

REFRESHMENT BREAK

LIVE CASE DEMONSTRATIONS: Holy Name Hospital and Kaiser Foundation HospitalModerator: Michael Dake, MDPanel: Robert Bersin, MD; Mark Burket, MD; Daniel Clair, MD; Robert Lookstein, MD; Gustavo Oderich, MD; Geoffrey Rubin, MD

LUNCH / SATELLITE SYMPOSIA

LATE-BREAKING CLINICAL TRIALS Moderator: Gary Ansel, MD

7:00 - 8:00 am

8:05 - 8:10 am

8:10 - 8:18 am

8:18 - 8:26 am

8:26 - 8:34 am

8:34 - 8:42 am

8:42 - 8:45 am

8:45 - 10:00 am

8:55 - 9:40 am

10:00 - 10:08 am

10:08 - 10:16 am

10:16 - 10:25 am

10:25 - 10:55 am

10:55 am - 12:00 pm

12:00 - 1:20 pm

1:20 - 2:00 pm

8:55 - 9:40 am

Chalk TalkPedal Loop Interventions: When, How, and What are the Results?Moderator: Tony Das, MDPanel: Lanfroi Graziani, MD; Marco Manzi, MD; Dierk Scheinert, MD; Thomas Zeller, MD

Located in Alsace 1

24

WEDNESDAY, OCTOBER 10, 2012 • DAY 2

Agenda subject to change.

JOIN US FOR A VIVA 12 CONCURRENT SESSION!

vv

8:55 am - 5:30 pm

INTErNaTIONal FOrUMInternational perspectives presented by world-renowned faculty.

FACE-OFF with VIVA FacultyA half-day competition series featuring international physicians and domestic fellows. Winnerswill advance to present in the International Forum.

Located in Margaux 1 See pages 31-32 for agenda.

v

8:10 am - 5:30 pm The Presentation BunkerA non-stop serving of cases, and nothing but cases ALL DAY!

Located in Margaux 2 See page 34 for agenda.

INTRO IN

INTRO IN

SPECIAL EVENT

2:00 - 3:00 pm DIalOG SESSIONHow to Better Manage Diabetic Vascular Disease: Is Diabetic Atheroma Different from Non-Diabetic Arterial Disease and Does it Matter?Moderator: Joshua Beckman, MDPanel: Subhash Banerjee, MD; Mark Burket, MD; Michael R. Jaff, DO; Richard Neville, MDLocated in Alsace 1

DIALOG SESSION

LIVE CASE DEMONSTRATIONS: Holy Name Hospital and Kaiser Foundation HospitalModerator: John Kaufman, MDPanel: Michael Fischbein, MD; Lawrence Garcia, MD; William Gray, MD; Nick Hopkins, MD; Dierk Scheinert, MD; Benjamin Starnes, MD

IlIAC & SFA

Why I Do What I Do: how the recent Trials and My Experience Inform My approach to Iliac Occlusive Disease: Stent-Grafts Versus Bare StentsAlan Matsumoto, MD

SPECIAL FEATURE – THIS IS HOW I DO IT: My “Go-To” Techniques for Recanalization and Re-Entry During Treatment of Total Occlusions James Joye, DO

Why I Do What I Do: When to Use Distal Embolic Protection and Lower Extremity Interventions Subhash Banerjee, MD

REFRESHMENT BREAK

CURRENT PRACTICE – ASSESSING YOUR PATIENT: How I Use Imaging to Stratify Patients with Femoropopliteal Disease into Specific Treatment Algorithms Robert Lookstein, MD

DEBATE: What Should We Currently Think of Atherectomy and Debulking?

Once Upon a Time, Debulking was a Promising Idea, but that Time is Gone Mahmood Razavi, MD

“Not so fast,” Recent Studies Show that Atherectomy is Better than Most Endovascular Procedures and It Leaves Nothing BehindLawrence Garcia, MD

Is There a Proven Value to Anti-Platelet Therapy After Endovascular PAD Procedures; if so, Does Everyone Need It or Only Certain Patients?Bruce Gray, DO

LIVE CASE DEMONSTRATIONS: Kaiser Foundation HospitalModerator: Gary Ansel, MDPanel: David Dawson, MD; Jason Lee, MD; Jihad Mustapha, MD; Alice Perlowski, MD; Richard Saxon, MD; Edward Woo, MD

DAY TWO CONCLUDES

2:00 - 3:00 pm

2:00 - 3:06 pm

3:06 - 3:14 pm

3:14 - 3:22 pm

3:22 - 3:30 pm

3:30 - 3:55 pm

3:55 - 4:03 pm

4:03 - 4:17 pm

4:17 - 4:25 pm

4:25 - 5:30 pm

5:30 pm

25

7:00 - 10:00 pm

CONCURRENT SESSIONS...Continued

ThE aNNIVErSarY GalaWednesday, October 10 @ Encore’s Club XSJoin us for VIVA’s 10th anniversary celebration! Attendance to the Anniversary Gala is included in your conference registration fee.

vINTErNaTIONal FOrUMInternational perspectives presented by world-renowned faculty.

Located in Margaux 1 See pages 31-32 for agenda.

The Presentation BunkerLocated in Margaux 2 See page 34 for agenda.

INTRO IN

INTRO IN

THURSDAY, OCTOBER 11, 2012 • DAY 3

26 Agenda subject to change.

Satellite Symposia

Review of Wednesday’s Live Cases John Rundback, MD

lInC FEATUREd SymPoSIUm:CRITICAl lImB ISChEmIA

CURRENT PRACTICE – ASSESSING YOUR PATIENT: My Diagnostic Evaluation of CLI and How It Influences My Treatment StrategyJames Benenati, MD

What Does the Angiosome Concept Practically Add to My Procedure Planning and Technique for Treating CLI Patients – is a Custom-Tailored Approach, the Future? John Rundback, MD

Is There a Hierarchical Clinical Benefit to Using Drug-Eluting Technologies Over POBA and Bare Stents for Tibial Disease; if so, in What Conditions and for What Lesions is It Obvious? Dierk Scheinert, MD

Why I Do What I Do: My approach to the Evaluation and Treatment Planning for Patients with a lower Extremity Ulcer Richard Neville, MD

ATLAS AWARD PRESENTATION (a Teacher, leader, and Scholar)Honoring John A. Spittell Jr., MD for his contribution to endovascular education and patient care. Presented by Michael R. Jaff, DO

LIVE CASE DEMONSTRATIONS: Park Hospital Leipzig, GermanyModerator: John Rundback, MDPanel: Matthew Eagleton, MD; Bruce Gray, DO; Lanfroi Graziani, MD; Ziv Haskal, MD; James Joye, DO; Eric Verhoeven, MD, PhD

CHALK TALK

REFRESHMENT BREAK

CRITICAl lImB ISChEmIA/TIBIAl

The Endovascular Approach to Acute Limb Ischemia: When and How to Use Thrombectomy and Thrombolysis David Dawson, MD

SPECIAL FEATURE – THIS IS HOW I DO IT: My Approaches to Alternative Lower Extremity Vascular Access: Popliteal, Tibial, and Pedal – When and How I Use Them Jihad Mustapha, MD

Step-by-Step Approach to Pedal Loop Interventions; How to Succeed Lanfroi Graziani, MD

LIVE CASE DEMONSTRATIONS: Park Hospital Leipzig, GermanyModerator: Kenneth Rosenfield, MDPanel: Mark Creager, MD; Clement Darling, MD; Mark Eskandari, MD; Nick Hopkins, MD; Alan Matsumoto, MD; Thomas Tsai, MD

LUNCH / SATELLITE SYMPOSIA

7:00 - 8:00 am

8:05 - 8:10 am

8:10 - 8:18 am

8:18 - 8:26 am

8:26 - 8:34 am

8:34 - 8:42 am

8:42 - 8:47 am

8:47 - 9:55 am

9:20 - 10:05 am

9:55 - 10:25 am

10:25 - 10:33 am

10:33 - 10:41 am

10:41 - 10:50 am

10:50 am - 12:00 pm

12:00 - 1:20 pm

JOIN US FOR A VIVA 12 CONCURRENT SESSION!

v

7:55 am - 5:30 pm

INTErNaTIONal FOrUMInternational perspectives presented by world-renowned faculty.

Located in Margaux 1 See pages 32-33 for agenda.

v

8:10 am - 5:30 pm The Hurt LockerComplications exposed and dissected by expert vascular operatives.

Located in Margaux 2 See page 35 for agenda.

9:20 - 10:05 am

Chalk TalkVenous Compression Syndromes: When to Consider, How to Diagnose, Available Treatment Options, and What to ExpectModerator: Michael Dake, MDPanel: Fritz Angle, MD; Clement Darling, MD; Jason Lee, MD; Suresh Vedantham, MDLocated in Alsace 1 INTRO IN

INTRO IN

1:20 - 2:00 pm

2:00 - 2:08 pm

2:08 - 2:16 pm

2:16 - 3:20 pm

2:20 - 3:20 pm

3:20 - 3:50 pm

3:50 - 3:57 pm

3:57 - 4:04 pm

4:04 - 4:11 pm

4:11 - 4:18 pm

4:18 - 4:25 pm

4:25 - 4:32 pm

4:32 - 5:30 pm

5:30 pm

INTRO IN

INTRO IN

27

2:20 - 3:20 pm DIalOG SESSIONThe Relationship of Blood Flow and Vascular Disease: Basic Science and Clinical Observations that Emphasize Important Pathophysiological PrinciplesModerator: Kenneth Rosenfield, MDPanel: Joshua Beckman, MD; Mark Creager, MD; Jon Matsumura, MD Located in Alsace 1

LATE-BREAKING CLINICAL TRIALS Moderator: Michael R. Jaff, DO

mISCEllAnEoUS

In-Stent Restenosis in the Visceral and Renal Arteries: Current Views on the Risk, Diagnosis, and Treatment Options Thomas Zeller, MD

Contemporary Surgical Approaches to the Evaluation and Management of Chronic Mesenteric Ischemia Mark Eskandari, MD

LIVE CASE DEMONSTRATIONS: Presbyterian Heart InstituteModerator: Peter Schneider, MDPanel: Subhash Banerjee, MD; Bruce Gray, DO; William Jordan, MD; Stephen Kee, MD; Dierk Scheinert, MD; Suresh Vedantham, MD

DIALOG SESSION

REFRESHMENT BREAK

CARoTId And STRokE

Where Do We Go After CREST? New Studies and Answers to Frequently Asked Questions in the Post-CREST Era Joshua Beckman, MD

Carotid Disease Stratification: Is Plaque Composition an Important Factor to Currently Consider Before Selecting Therapy? Jon Matsumura, MD

CURRENT PRACTICE – ASSESSING YOUR PATIENT: My Decision Tree When Approaching a Symptomatic Patient with Carotid Artery DiseaseClement Darling, MD

New Strategies, Devices, and Techniques for Carotid Artery Stenting: Opportunities to Improve Outcomes or is This as Good as it Gets?John Laird, MD

Acute Stroke Intervention: Is There Something We’re Missing?Nick Hopkins, MD

Intracranial Update: Current Status of Stents, Flow Diversion, Embolization, etc., to Treat Neurovascular Lesions Colin Derdeyn, MD

LIVE CASE DEMONSTRATIONS: Presbyterian Heart InstituteModerator: James Joye, DOPanel: Mark Creager, MD; Colin Derdeyn, MD; Mark Farber, MD; Zvonimir Krajcer, MD; Gary Siskin, MD

DAY THREE CONCLUDES/SATELLITE SYMPOSIA

CONCURRENT SESSIONS...Continued

vINTErNaTIONal FOrUMInternational perspectives presented by world-renowned faculty.

Located in Margaux 1 See pages 32-33 for agenda.

The Hurt LockerLocated in Margaux 2 See page 35 for agenda.

FOR UPDATED PROGRAM INFORMATION VISIT www.VIVAPVD.com

FRIDAY, OCTOBER 12, 2012 • DAY 4

Review of Thursday’s Live Cases Peter Schneider, MD

ABdomInAl AoRTA

DEBATE: Endovascular AAA Treatment of Proximal Aortic Necks Less than 10mm is Currently One of the Biggest Challenges for EVAR – What Works?

New Endograft Designs that Enhance Infra-Renal Sealing and Provide Supra-Renal Fixation Allow Us to Confidently Manage Short Necks Down to 5mm Matthew Eagleton, MD

Stop Kidding Yourself, the Only Way to Securely Treat this Type of Anatomy is to Use Fenestrated Devices in All Such Cases Eric Verhoeven, MD, PhD

SPECIAL FEATURE – THIS IS HOW I DO IT: My Complex EVAR Strategies for Graft Selection, Sizing, and Procedure Choreography, etc. Mark Farber, MD

In this Era, EVAR Should be Performed Percutaneously Whenever Possible and Here’s the Evidence Why It’s Best for Patients Zvonimir Krajcer, MD

DEBATE: Hybrid Procedures Versus Total Endovascular Management: What’s Possible for Total Arch and Thoracoabdominal Aortic Repair Now and in the Future?

The Hybrid Combination of Open and Endo Repair is Less Risky than Standard Surgery and for the Conceivable Future It is the Only Practical Approach Capable of Being Performed at Most Centers William Jordan, MD

“Hold on a Minute,” Hybrid Aortic Surgery is No Safer than Traditional Operative Repair; Total Endovascular Branch Solutions are Feasible and Ultimately, the Best Solution for Most Patients Gustavo Oderich, MD

THE WISDOM OF PERSPECTIVE – The Three Most Important Challenges Facing EVAR Today Roger Greenhalgh, MD

Cone Beam CT, Image Fusion, and Advanced Guidance in the Angio Suite: When I Most Appreciate the Benefits of What Leading-Edge Imaging Can Contribute Constantino Peña, MD

8:00 - 8:05 am

8:05 - 8:19 am

8:19 - 8:27 am

8:27 - 8:35 am

8:35 - 8:49 am

8:49 - 8:56 am

8:56 - 9:03 am

28 Agenda subject to change.

Ultrasound, CT, and MR Imaging Follow-up are All Possible, But Here’s My Surveillance Algorithm for When and How I Follow PatientsPeter Schneider, MD

Type II Endoleaks with an Enlarging Sac are Problematic – Here’s the Best Plan to Deal with Them Stephen Kee, MD

What Does “Health Care Reform” Really Mean to the Practicing Vascular Specialist? Kenneth Rosenfield, MD

How Will Hospital Systems Influence Purchasing of Devices in the Era of Cost Containment? Sean Lyden, MD

The “Business” Case for Multispecialty Collaboration - Why This Will be Critical for Survival of the Vascular Specialist Michael R. Jaff, DO

REFRESHMENT BREAK

VIVA 10th ANNIVERSARY LECTURE: “Houston, We Have a Problem” - Dealing With In-stent Restenosis Once It Happens...What Works and What Doesn’t Thomas Tsai, MD

vEnoUS/ThRomBoEmBolIC

CURRENT PRACTICE – ASSESSING YOUR PATIENT: What Supports My Decision to Intervene or Conservatively Treat Patients with Acute DVTSuresh Vedantham, MD

Why I Do What I Do: how Emerging agents have Changed My approach to VTE Joshua Beckman, MD

New Endovascular Procedures to Manage Life-Threatening Pulmonary Embolism: What Criteria are Used to Intervene and What are the Results? Gary Ansel, MD

Practice Trends: IVC filters – is the U.S. Completely Out of Step with the Rest of the World: What’s New and Where are We Headed?Ziv Haskal, MD

What’s the Status of CCSVI and Its Association with Multiple Sclerosis and Other Neurodegenerative Diseases: is It Getting Clearer or More Confusing? Gary Siskin, MD

Current Controversies and Recent Advances in the Endovascular Management of Varicose Veins Scott Resnick, MD

Experience with Stent-Grafts, Drug-Eluting Stents, and Drug-Coated Balloons for Dialysis Access Lesions: What We’ve LearnedAnne Roberts, MD

10th Anniversary Rapid Fire Triumphs and Tragedies: Valuable Tips, Teaching Points, and Take-Home Messages from the Most Enlightening Cases of 2012

VIVA 12 CONCLUDES

9:03 - 9:10 am

9:10 - 9:17 am

9:17 - 9:25 am

9:25 - 9:33 am

9:33 - 9:41 am

9:41 - 9:56 am

9:56 - 10:04 am

10:04 - 10:12 am

10:12 - 10:20 am

10:20 - 10:28 am

10:28 - 10:36 am

10:36 - 10:44 am

10:44 - 10:52 am

10:52 - 11:00 am

11:00 am - 12:00 pm

12:00 pm

29

3

SAVE THE DATE!

JOIN US NExT YEAR OCTOBER 8 -11,

2013

30 Agenda subject to change.

CONCURRENT SESSION AGENDAS

Opening BellHost: Michael Dake, MD

Squawk in the SuiteHost: Michael Dake, MD

REFRESHMENT BREAK

PTI: Pardon the InterventionsHost: Michael R. Jaff, DO

Power Lunch

9:00 - 10:00 am

Timothy Sullivan, MD

William Gray, MD

Jeffrey Olin, DO

James Benenati, MD

Kenneth Rosenfield, MD

Robert Lookstein, MD

Jason Lee, MD

D. Christopher Metzger, MD

John Rundback, MD

10:40 - 11:40 am

Manish Mehta, MD

Dierk Scheinert, MD

Alan Lumsden, MD

Richard Saxon, MD

Lawrence Garcia, MD

Edward Woo, MD

Sean Lyden, MD

Lanfroi Graziani, MD

Mahmood Razavi, MD

2:20 - 3:20 pm

Benjamin Starnes, MD

John Laird, MD

David Deaton, MD

Constantino Peña, MD

Scott Resnick, MD

Robert Bersin, MD

Michael Fischbein, MD

Marco Manzi, MD

Suresh Vedantham, MD

1:20 - 2:20 pm

Jason Lee, MD

Tony Das, MD

Jon Matsumura, MD

Mahmood Razavi, MD

Fritz Angle, MD

Christopher Kwolek, MD

Gustavo Oderich, MD

Thomas Zeller, MD

John Rundback, MD

3:50 - 4:50 pm

Clement Darling, MD

Mark Burket, MD

Richard Neville, MD

Gary Siskin, MD

Ziv Haskal, MD

Daniel Clair, MD

Thoralf Sundt, MD

William Gray, MD

John Kaufman, MD

Endovascular HardballHost: Joshua Beckman, MD

World Angio TodayHost: Tony Das, MD

REFRESHMENT BREAK

Cath Lab 360°Host: Kenneth Rosenfield, MD

Closing Bell

8:55 - 9:00 am

9:00 - 10:00 am

10:00 - 10:40 am

10:40 - 11:40 am

12:00 pm - 1:20 pm

ABdOMINALAORTA

Carotid /Stroke

iliaC

MeSenteriC /Portal

renal

SFa

thoraCiCaorta

tibial /Pedal

VenouS

1:20 - 2:20 pm

2:20 - 3:20 pm

3:20 - 3:50 pm

3:50 - 4:50 pm

4:50 pm

VIVA VOCE [vo cha] Tuesday, October 9, 8:55 am - 4:50 pm in Margaux 1 Join us for one-on-one “hot-seat” interviews with VIVA faculty! Please see page 13 for full course description.

Continuing medical education credits are not available for this session.

The BLITZ!

Tuesday, October 9, 8:55 am - 4:50 pm in Margaux 1

During every hour of this session, 9 “vascular stations” will each offer an 8-minute presentation on a different

topic by VIVA faculty. Every 10 minutes, attendees rotate and choose which stations to visit within the hour. Please see

page 13 for full course description. Continuing medical education credits are not available for this session.

The endovascular equivalent ofa “Speed Dating” experience!

Don’t Miss This! Same room, same time...

31

FACE-OFF wITh VIVA FACulTy 8:55 am - 12:00 pm in Margaux 1

Before the official start of the International Forum, join us for this lightning-fast electronic competition series

featuring presentations from fellows and international physicians. Please see page 14 for full course description.

Continuing education credits are not available for this session.

INTERNATIONAL FORUM

AGENDAWEDNESDAY, OCTOBER 10, 2012

Kick-off with FACE-OFF!

Welcome Manish Mehta, MD

LIgHTNINg ROuNd FACE-OFF WITH VIVA FACuLTy

global Issues with Vascular Awareness and Endovascular Training: ChinaWei Guo, MD

LIgHTNINg ROuNd FACE-OFF WITH VIVA FACuLTy

global Issues with Vascular Awareness and Endovascular Training: IndiaVarinder Bedi, MD

LIgHTNINg ROuNd FACE-OFF WITH VIVA FACuLTy

global Issues with Vascular Awareness and Endovascular Training: JapanDaisuke Fukui, MD, PhD

LuNCH ANd SATELLITE SyMPOSIA

International Forum moves to Lafleur 1 & 2

Program Introduction

1ST FACE-OFF PRESENTATION

What’s Best for Iliac Artery Occlusive disease: Stents or Stent-grafts? Jacques Busquet, MD

Optimal Strategy for Taming the SFA: PTA, debulking, or Stents? Andrew Holden, MD

Where does debulking Work Best: Lesion-Specific Approach to Atherectomy John Laird, MD

How do We Safely Adopt the ‘Endo-First’ Approach for Most CLI Patients Roberto Beck, MD

Tibial Recanalization: Tips and Tricks that Really Work Lanfroi Graziani, MD

Best Treatment Strategy for Infrainguinal ‘Endo-First’ Failures Walter Dorigo, MD

8:55 - 9:00 am

9:00 - 9:50 am

9:50 - 10:00 am

10:00 - 10:50 am

10:50 - 11:00 am

11:00 - 11:50 am

11:50 am - 12:00 pm

12:00 - 1:00 pm

1:00 pm

1:00 - 1:02 pm

1:02 - 1:12 pm

1:12 - 1:20 pm

1:20 - 1:28 pm

1:28 - 1:36 pm

1:36 - 1:44 pm

1:44 - 1:52 pm

1:52 - 2:00 pm

InTErnATIOnAl FOrum 12:00 - 5:30 pm in Lafleur 1 & 2

A two-day symposium highlighting perspectives and interventional experiences from around the world.

Live cases will be broadcast in real-time from the General Session. Please see page 14 for full course

description. This session is accredited for 4.0 credits on Wednesday and 8.0 credits on Thursday.

32 Agenda subject to change.

LIVE CASE dEMONSTRATIONS Moderator: John Laird, Md Panel: Varinder Bedi, Md; Lanfroi graziani, Md; Andrew Holden, Md; Hence Verhagen, Md

2Nd FACE-OFF PRESENTATION

REFRESHMENT BREAK

A CX Great Debate: drug Elution for Infrainguinal Reconstructionis Clinically Beneficial and Worth the Extra Money Pro: Dierk Scheinert, MD; Thomas Zeller, MDCon: Andrew Holden, MD; Frans Moll, MD, PhD

Audience Participation and Voting Moderator: Roger greenhalgh, Md

LIVE CASE dEMONSTRATIONS Moderator: Kenneth Rosenfield, MdPanel: Walter dorigo, Md; Roger greenhalgh, Md; Pankaj Patel, MBBS; Thomas Zeller, Md

Adjourn

Welcome Gary Ansel, MD

3Rd FACE-OFF PRESENTATION

What Can We Learn About Limb Salvage from the diabetic Capital of the World, India? Pankaj Patel, MBBS

Bioresorbable Vascular Scaffolds: Hope or Hype? Koen Deloose, MD

How Will CREST Influence CAS Worldwide and What is the Future of Cerebral Protection?Sumaira Macdonald, MD

TAVR, the Opportunity for True Multidisciplinary Collaboration in Everyday Clinical Practice Augustin DeLago, MD

LIVE CASE dEMONSTRATIONS Moderator: gary Ansel, MdPanel: Roberto Beck, Md; Koen deloose, Md; Sumaira Macdonald, Md; Pankaj Patel, MBBS

The Holy grail of EVAR are New Emerging Percutaneous devices that Treat Complex Aortic NecksFerdinand Serracino-Inglott, MD

Fenestrated and Branched Stent-grafts are the Ideal Solution for Pararenal and Juxtarenal AAAAndrew Holden, MD

Bail-Out Techniques Everyone Needs to Know When Treating Complicated EVARPierre Galvagni Silveira, MD, PhD

A CX Debate: Instructions for use are for Beginners Pro: Eric Verhoeven, MD, PhDCon: Hence Verhagen, MD

2:00 - 3:15 pm

3:15 - 3:25 pm

3:25 - 3:55 pm

3:55 - 4:15 pm

4:15 - 4:25 pm

4:25 - 5:30 pm

5:30 pm

7:55 - 8:00 am

8:00 - 8:10 am

8:10 - 8:20 am

8:20 - 8:30 am

8:30 - 8:40 am

8:40 - 8:50 am

8:50 - 10:00 am

10:00 - 10:10 am

10:10 - 10:21 am

10:21 - 10:32 am

10:32 - 10:42 am

INTERNATIONAL FORUM

WEDNESDAY, OCTOBER 10, 2012 Continued..

InTErnATIOnAl FOrum 7:55 am - 5:30 pm in Lafleur 1 & 2

THuRSDAY, OCTOBER 11, 2012

33

Audience Participation and Voting Moderator: Roger greenhalgh, Md

LIVE CASE dEMONSTRATIONS Moderator: Manish Mehta, Md Panel: Augustin deLago, Md; Ferdinand Serracino-Inglott, Md; Pierre galvagni Silveira, Md, Phd; Eric Verhoeven, Md, Phd

LuNCH / SATELLITE SYMPOSIA

4TH FACE-OFF PRESENTATION

Tips and Tricks for Successful Ruptured EVAR and TEVAR Manish Mehta, MD

Can Robotics Steer Their Way into Endovascular Catheter-Based Procedures? Nick Cheshire, MD

understanding Imaging is the Key to Managing Thoracic Aortic Aneurysms and dissectionsPeter Taylor, MD

Branched devices are the Answer to All Complex Thoracic Aortic Aneurysms Marcelo Ferreira, MD

Overcoming Technical Challenges of Thoracic Arch Aneurysms; New Techniques and devices Wei Guo, MD

The Sandwich Technique uses Off-the-Shelf devices for Treating Complex Thoracoabdominal Aneurysms Armando Lobato, MD

TEVAR in 2020, a Sneak Preview into the Future Vincent Riambau, MD, PhD

5TH FACE-OFF PRESENTATION

LIVE CASE dEMONSTRATIONS Moderator: James Joye, dOPanel: Nick Cheshire, Md; Wei guo, Md; Vincent Riambau, Md, Phd; Peter Taylor, Md

REFRESHMENT BREAK

TEVAR for Complicated Type B dissections, Avoiding Pitfalls is the Key to Success Hence Verhagen, MD

What Should We Expect Following TEVAR for Complicated Type B dissections, Surveillance, and Secondary Procedures? Armando Lobato, MD

6TH FACE-OFF PRESENTATION

A CX Debate: It is Reasonable to Cover and Exclude theLeft Subclavian Artery during Aortic Arch Reconstruction Pro: Peter Taylor, MDCon: Vincent Riambau, MD, PhD

Audience Participation and Voting Moderator: Roger greenhalgh, Md

LIVE CASE dEMONSTRATIONS Moderator: Manish Mehta, MdPanel: Marcelo Ferreira, Md; Armando Lobato, Md; Roberto Sacilotto, Phd; Hence Verhagen, Md

Award Presentation: Face-Off Winners

10:42 - 10:52 am

10:52 am - 12:00 pm

12:00 - 1:00 pm

1:00 - 1:10 pm

1:10 - 1:18 pm

1:18 - 1:26 pm

1:26 - 1:34 pm

1:34 - 1:42 pm

1:42 - 1:50 pm

1:50 - 1:58 pm

1:58 - 2:06 pm

2:06 - 2:16 pm

2:16 - 3:20 pm

3:20 - 3:50 pm

3:50 - 3:58 pm

3:58 - 4:06 pm

4:06 - 4:16 pm

4:16 - 4:26 pm

4:26 - 4:36 pm

4:36 - 5:30 pm

5:30 pm

THuRSDAY, OCTOBER 11, 2012 Continued..

FOR uPdATEd PROgRAM INFORMATION VISIT www.VIVAPVD.com

34

Sessions located in Margaux 2 Please see page 15 for full course description. Continuing education credits are not available for this session.

AGENDA

Agenda subject to change.

WED

NES

DA

Y A

GEN

DA

Mesenteric/Renal Lieutenant: Kenneth Rosenfield, MdPlatoon: Robert Bersin, Md; Andrew Holden, Md; Jihad Mustapha, Md; Mahmood Razavi, Md; gary Siskin, Md

Dialysis/IVC Filters Lieutenant: John Kaufman, MdPlatoon: Fritz Angle, Md; Robert Lookstein, Md; Richard Neville, Md; Pankaj Patel, MBBS; Constantino Peña, Md

DVT/Venous Obstruction/PE Lieutenant: Michael dake, MdPlatoon: James Benenati, Md; Mahmood Razavi, Md; Richard Saxon, Md; Suresh Vedantham, Md;

Carotid/Stroke Lieutenant: Tony das, MdPlatoon: William gray, Md; Sumaira Macdonald, Md; d. Christopher Metzger, Md; dierk Scheinert, Md; Frank Veith, Md

Thoracic Aorta Lieutenant: Sean Lyden, MdPlatoon: Marcelo Ferreira, Md; Jason Lee, Md; Alan Lumsden, Md; gustavo Oderich, Md; Peter Taylor, Md

Abdominal Aorta Lieutenant: Manish Mehta, MdPlatoon: Nick Cheshire, Md; daniel Clair, Md; david deaton, Md; Armando Lobato, Md; Timothy Sullivan, Md

Iliofemoral PAD Lieutenant: Sean Lyden, MdPlatoon: Varinder Bedi, Md; Jacques Busquet, Md; Christopher Kwolek, Md; Jon Matsumura, Md; Benjamin Starnes, Md

CLI/Tibial/Pedal Lieutenant: John Laird, MdPlatoon: Subhash Banerjee, Md; Lawrence garcia, Md; Lanfroi graziani, Md; Marco Manzi, Md; Scott Resnick, Md

8:10 - 8:55 am

8:55 - 9:40 am

9:40 - 10:25 am

11:00 - 11:55 am

1:30 - 2:25 pm

2:25 - 3:20 pm

4:00 - 4:45 pm

4:45 - 5:30 pm

wedneSday, oCtober 10, 2012

ThE PrESEnTATIOn BunKEr: Case-Based Instruction

DAY 1

35

Th

ur

SDA

Y A

GEN

DA

thurSday, oCtober 11, 2012

Renal Lieutenant: Michael R. Jaff, dOPlatoon: Subhash Banerjee, Md; Mark Burket, Md; Andrew Holden, Md;Jihad Mustapha, Md; Thomas Zeller, Md

Mesenteric/Portal Lieutenant: John Kaufman, MdPlatoon: James Benenati, Md; Stephen Kee, Md; Alan Matsumoto, Md; gary Siskin, Md

Endovascular Valve/Embolization Lieutenant: James Joye, dOPlatoon: Ziv Haskal, Md; Zvonimir Krajcer, Md; Alice Perlowski, Md; dierk Scheinert, Md

Venous Lieutenant: John Rundback, MdPlatoon: Ziv Haskal, Md; Stephen Kee, Md; Pankaj Patel, MBBS; Richard Saxon, Md; Suresh Vedantham, Md

Arch Branch/Carotid Lieutenant: gary Ansel, MdPlatoon: Clement darling, Md; Colin derdeyn, Md; Nick Hopkins, Md; Zvonimir Krajcer, Md; Sumaira Macdonald, Md

Thoracic Aorta Lieutenant: Michael dake, MdPlatoon: Mark Farber, Md; Marcelo Ferreira, Md; Alan Matsumoto, Md; Ramon Varcoe, Md; Hence Verhagen, Md

Abdominal Aorta Lieutenant: Peter Schneider, MdPlatoon: Mark Eskandari, Md; gustavo Oderich, Md; Ferdinand Serracino-Inglott, Md; Frank Veith, Md; Eric Verhoeven, Md, Phd

PAD Lieutenant: John Laird, MdPlatoon: Koen deloose, Md; Ziv Haskal, Md; William Jordan, Md; Scott Resnick, Md; Thomas Tsai, Md

8:10 - 9:05 am

9:05 - 10:00 am

10:35 - 11:15 am

11:15 am - 12:00 pm

1:30 - 2:25 pm

2:25 - 3:20 pm

3:50 - 4:40 pm

4:40 - 5:30 pm

ThE hurT lOCKEr: Complications Exposed DAY 2

ThE

SiTuATioN

room

36

LOCATION & HOTEL INFORMATION

WyNN LAs VEgAs3131 LAs VEgAs BOuLEVARd sOuTH

LAs VEgAs, NEVAdA 89109

RESERVATIONSVIVA 12 will be held at Wynn Las Vegas from October 9-12, 2012. Wynn

Las Vegas is located at the north end of the Las Vegas strip and about 3

miles from the McCarran International Airport.

A block of rooms at a discounted rate of $189 per night plus tax has been

reserved for VIVA participants. Rooms are available on a first-come, first-

served basis until the cut-off date of September 10, 2012, or until the

block fills, whichever comes first. After that date, reservations and/or

changes will be subject to availability. A deposit of the first night’s room

and tax will be required to confirm all reservations.

The maximum number of occupants per room is four, regardless of age.

There is an additional charge of $50 per person for each guest over

double occupancy.

To reserve a hotel room at the VIVA discounted rate, log onto www.VIVAPVD.com/conference

and select “Hotel Information” under the “Conference Overview” tab.

REGISTRATION & ChECk-INVIVA Registration offers on-site registration and check-in service for pre-registered attendees. Remember to bring your registration confirmation email which contains your express check-in barcode! Please make every effort to check-in prior to the start of VIVA on Tuesday morning.

Registration desk 2 is available during the following hours:

Saturday, October 6 10:00 am - 5:15 pmSunday, October 7 7:30 am - 5:15 pmMonday, October 8 6:30 am - 6:15 pmTuesday, October 9 6:00 am - 5:45 pmWednesday, October 10 7:30 am - 7:15 pmThursday, October 11 7:30 am - 5:40 pmFriday, October 12 7:30 am - 12:00 pm

A separate Industry Representative registration/check-inarea is located in the Montrachet Foyer near Registration desk 2 and will be available during the following hours:*

Monday, October 8 10:00 am - 6:15 pmTuesday, October 9 6:00 am - 3:00 pm

*Industry will be able to check-in on saturday, sunday, and after 3pm onTuesday at Registration desk 2.

CONCIERGE DESkA concierge will be in the Exhibit Pavilion from Tuesday – Thursday to assist with dinner and entertainment reservations, ground transportation, and other services exclusively for VIVA attendees.

Tuesday, October 9 9:30 am - 4:00 pmWednesday, October 10 9:30 am - 4:00 pmThursday, October 11 9:30 am - 4:00 pm

ExhIbIT hOuRS – LATOuR bALLROOMTuesday, October 9 7:00 am - 4:00 pmWednesday, October 10 7:30 am - 4:00 pmThursday, October 11 9:30 am - 4:00 pm

37

COMMERCIAL SuPPORTERS

VIVA 12

gLOBAL PREMIER• Abbott VAsculAr• bArD PErIPHErAl VAsculAr• boston scIEntIfIc corPorAtIon• cook MEDIcAl • GorE & AssocIAtEs• MEDtronIc VAsculAr, Inc.

PREMIER BENEFACTOR• corDIs corPorAtIon, a Johnson & Johnson company • coVIDIEn

AFFILIATE• bAYEr IntErVEntIonAl

CONTRIBuTOR• cArDIoVAsculAr sYstEMs, Inc.• sPEctrAnEtIcs• trIVAsculAr, Inc.

suBsCRIBER• AstrAZEnEcA

suPPORTER• st. JuDE MEDIcAl

CLI AND LIMB PRESERVATION • Abbott VAsculAr• bArD PErIPHErAl VAsculAr• cook MEDIcAl• GorE & AssocIAtEs

INTERNATIONAL FORUM • Abbott VAsculAr• GorE & AssocIAtEs• trIVAsculAr, Inc.

VENOUS INTERVENTIONS • coVIDIEn

iPAD APP DEVELOPMENT• GorE

VIVA 12 ExhIbITORS• Abbott Vascular• AccessClosure, Inc.• ACIST Medical Systems• AngioDynamics• AngioScore• Aptus Endosystems, Inc.• Argon Medical Devices• Arstasis, Inc.• ASAHI INTECC USA, INC.• Bard Peripheral Vascular• BioCardia, Inc.• Boston Scientific Corporation• Cardiovascular Systems, Inc.• Cook Medical• Cordis Corporation• Covidien• Crux Biomedical, Inc.• EKOS Corporation• Endologix, Inc.• Endovascular Today• Gore & Associates• HMP Communications• IDEV Technologies, Inc.• International Society of Endovascular Specialists (ISES)• International Symposium on Endovascular Therapeutics (SITE 2013)• ISIS Services• Knobbe Martens Olson & Bear LLP• LINC 2013• Medtronic Vascular, Inc.• Merit Medical• Society for Cardiovascular Angiography and Interventions (SCAI)• Society of Interventional Radiology (SIR) • Spectranetics• St. Jude Medical • The International Symposium on Endovascular Therapy (ISET)• TriVascular, Inc.• Vascular Solutions• VEIN Magazine/VeinDirectory.org• Volcano Corporation

*View a current list of supporters and exhibitors at www.VIVAPVD.com

COMMERCIAL suPPORTERs ANd ExHIBITORs VIVA would like to thank the following commercial supporters and exhibitors:*

Please join us for this special opportunity to learn from world-renowned faculty, engage leading experts, and connect with dedicated colleagues.

In order to take advantage of VIVA’s early bird tuition listed below, please register by Tuesday, July 31.

Tuition increases will take effect on August 1 and september 25. The tuition fees include course materials

and attendance to all sessions including one Monday Pre-symposium and the Anniversary gala. Payment in

full is required to confirm your registration.

38

ThERE ARE 3 EASY WAYS TO REGISTER:

1. Visit www.VIVAPVD.com to register online2. call VIVA at 888-513-32443. use the new VIVA iPad App

REgIsTRATION

REGISTER TODAY!

Physician Tuition International physicians participating in the Face-Off may be eligible for complimentary tuition

Cardiovascular Healthcare Professional (CHP) Tuition Includes 3-day CHPs session and VIVA

Military Physician* and Resident* Tuition

Industry Professional Tuition (non-exhibitors) Exhibitors should register directly with their company representative

Fellows* Tuition Fellows participating in the Face-Off will receive complimentary tuition.Fellows who do not wish to submit a case for the Face-Off may attendVIVA for a $500 registration fee.

VEBRC Tuition

First-time Podiatrist Tuition Includes CLI pre-symposium and VIVA. License number required

Non-physician Tuition

*Must provide verification letter.

$1,295

$895

$895

$995

FREE

$995

$450

$995

Enter contest code when you register for a chance to win daily prizes at VIVA

contestcode33512

Scan this mobile barcode for more information.

REFuNDS/CANCELLATION POLICYCancellations received by August 31, 2012 will be accepted less a 15% administrative fee. No refunds will be given after that date. Refunds or credits will not be given for failure to attend, late arrival, unattended events, or early departure. VIVA must be notified in writing of your intent to cancel prior to the cancellation deadline. Fax your cancellation notification to VIVA Cancellation at 408-225-3240, or mail your cancellation notification to VIVA Cancellation at 5671 santa Teresa Blvd, suite 202, san Jose, CA 95123. Please note, in the event that VIVA 12 is abbreviated or canceled because of circumstances beyond the control of VIVA Physicians, including, but not limited to, civil disturbance, earthquake, electrical outage, explosion, fire, freight embargo, strike or labor unrest, flood, hurricane, tornado, or other acts of god, an act of war, terrorism, or the act of any government (de facto or de jure), or any government agency or official, VIVA Physicians reserves the right, at its sole discretion, to unilaterally terminate the symposium. In these circumstances, the registrant expressly agrees to waive any claim that they may have against VIVA Physicians for damages or compensation, including, but not limited to, fees for registration, housing, airfare, and/or incidental charges.

39

ThE PREMIER MuLTIDISCIPLINARY VASCuLAR EDuCATION EVENTThE PREMIER MuLTIDISCIPLINARY VASCuLAR EDuCATION EVENT

10A n n i v e r s A r yTH

NONPROFIT ORGUS POSTAGE

PAIDSAN JOSE, CA

PERMIT NO. 828

VIVA Physicians, Inc.

5671 santa Teresa Blvd. suite 202san Jose, CA 95123

A Not For Profit Organization dedicated To Vascular Education And Research

www.VIVAPVD.com • 888-513-VIVA (8482)

Endorsed By:

Official Publication: